Accelerated approval: FDA revises guidance to reflect revised withdrawal procedures
Regulatory NewsFerdous Al-Faruque
Biologics/ biosimilars/ vaccinesGuidancePharmaceuticalsRegulatory Intelligence/PolicyUnited StatesUS Food and Drug Administration (FDA)